5-year outcomes in the NBRST trial: preoperative MammaPrint and BluePrint breast cancer subtype is associated with neoadjuvant treatment response and survival
PUBLICATION: SABCS 2020 AUTHORS: Pat Whitworth, James V Read More
PUBLICATION: SABCS 2020 AUTHORS: Pat Whitworth, James V Read More
PUBLICATION: SABCS 2020 AUTHORS: Iris Noordhoek, Esther Bastiaannet, Ersan Read More
PUBLICATION: SABCS 2020 AUTHORS:Ian E Krop, Lorenza Mittempergher, Joseph N Read More
Publication: Soliman et al. BMC Cancer (2020) 20:81 Authors: Read More
PUBLICATION: AMP 2020 AUTHORS: Douglas Kingma, Kasey Lawrence, Sahra Read More
PUBLICATION: ESMO 2020 AUTHORS: Mark Opdam, Vincent van der Noort, Read More
PUBLICATION: ESMO 2020 AUTHORS: Josien C. Haan, Rajith Bhaskaran, Lorenza Read More
PUBLICATION: European Journal of Cancer AUTHORS: Valesca P. Retel, Read More
I-SPY2, JAMA Oncology, 2020 Authors: Yee et al.
Read MorePUBLICATION: Communications Biology AUTHORS: Laurent Jacob, Anke Witteveen, Inès Beumer, Read More